tetano
Editor, Senior Moderator
Clin Infect Dis. 2018 Dec 9. doi: 10.1093/cid/ciy1042. [Epub ahead of print]
[h=1]Molecular point-of-care testing for influenza to improve early neuraminidase inhibitor treatment and outcomes in hospitalised adults.[/h] Brendish NJ[SUP]1,[/SUP][SUP]2[/SUP], Clark TW[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3,[/SUP][SUP]4[/SUP].
[h=3]Author information[/h]
PMID: 30541020 DOI: 10.1093/cid/ciy1042
[h=1]Molecular point-of-care testing for influenza to improve early neuraminidase inhibitor treatment and outcomes in hospitalised adults.[/h] Brendish NJ[SUP]1,[/SUP][SUP]2[/SUP], Clark TW[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3,[/SUP][SUP]4[/SUP].
[h=3]Author information[/h]
PMID: 30541020 DOI: 10.1093/cid/ciy1042